Multiple sclerosis

Multiple sclerosis is a presumably autoimmune-mediated disease of the central nervous system. An inflammatory reaction causes damage to the myelin sheath and nerve structures. We are working on a number of scientific issues:

Clinical studies in the field of MS therapy range from phase II to phase IV studies as well as smaller, academically initiated, so-called Investigator Initiated Trials (IIT).

Translationally, we deal with biomarkers in the cerebrospinal fluid. We use both traditional diagnostic methods and modern methods such as mass spectroscopy.

In the area of basic research, the focus of our work is on the mechanisms of how regeneration with remyelination occurs and how this can be improved. We use both cell cultures and animal models.